# Anavex Life Sciences Corp. (AVXL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AVXL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -40.90M | $ -34.89M | $ 0 | $ 126.62M |
| 2024 | $ 0 | $ -48.87M | $ -37.43M | $ 0 | $ 110.92M |
| 2023 | $ 0 | $ -46.66M | $ -31.69M | $ 0 | $ 135.58M |
| 2022 | $ 0 | $ -55.93M | $ -29.64M | $ 0 | $ 135.12M |
| 2021 | $ 0 | $ -48.66M | $ -30.92M | $ 0 | $ 146.37M |
| 2020 | $ 0 | $ -35.09M | $ -29.85M | $ 0 | $ 46.30M |
| 2019 | $ 0 | $ -31.29M | $ -25.93M | $ 0 | $ 25.96M |
| 2018 | $ 0 | $ -26.83M | $ -17.33M | $ 0 | $ 17.22M |
| 2017 | $ 0 | $ -19.36M | $ -12.78M | $ 0 | $ 25.55M |
| 2016 | $ 0 | $ -19.16M | $ -12.58M | $ 0 | $ 19.18M |
| 2015 | $ 0 | $ -21.45M | $ -9.52M | $ 82.7K | $ 11.49M |
| 2014 | $ 0 | $ -17.68M | $ -4.12M | $ 5.26M | $ 473.1K |
| 2013 | $ 0 | $ -4.11M | $ -1.54M | $ 200.4K | $ -1.67M |
| 2012 | $ 0 | $ -9.51M | $ -1.06M | $ 599.0K | $ -3.33M |
| 2011 | $ 0 | $ -10.50M | $ -5.59M | $ 1.16M | $ -2.48M |
| 2010 | $ 0 | $ -12.65M | $ -7.42M | $ 200.0K | $ -93.6K |
| 2009 | $ 0 | $ -7.63M | $ -5.01M | $ 2.55M | $ -4.48M |
| 2008 | $ 0 | $ -8.12M | $ -3.13M | $ 1.68M | $ -2.76M |
| 2007 | $ 0 | $ -3.87M | $ -1.50M | $ 200.0K | $ -368.1K |
| 2006 | $ 0 | $ -43.0K | $ -59.2K | $ 20.0K | $ -27.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 20.87 |

## Other views

- [Metrics](https://sponda.capital/en/AVXL.md)
- [Charts](https://sponda.capital/en/AVXL/charts.md)
- [Compare](https://sponda.capital/en/AVXL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.